HYBRID EVENT: You can participate in person at Valencia, Spain or Virtually from your home or work.
COVID-19 Drug Development

COVID-19 drug development is a research process to discover a preventative and therapeutic prescription of drugs that would control the severity of coronavirus disease. From 2020 to 2021, various drug companies, biotechnology firms, university research groups, and health organizations were started developing over 600 potential therapies for corona virus disease with various stages of preclinical or clinical research, with 391 therapeutic candidates in clinical trials, as of January 2021.

Committee Members
Speaker at Drug Delivery Events - Yong Xiao Wang

Yong Xiao Wang

Albany Medical College, United States
Speaker at Pharmaceutical Conference - Consolato M Sergi

Consolato M Sergi

Universities of Alberta and Ottawa, Canada
Speaker at Drug Delivery Events - Vladlen Slepak

Vladlen Slepak

University of Miami Miller School of Medicine, United States
Speaker at Drug Delivery Events -  Andreas M Papas

Andreas M Papas

Antares Health Products, United States
PDDS 2025 Speakers
Speaker at Pharmaceutical Conference - Axel H Schonthal

Axel H Schonthal

University of Southern California, United States
Speaker at Pharmaceutical Conference - Bernd Blobel

Bernd Blobel

University of Regensburg, Germany
Speaker at Pharmaceutical Conference - Srividya Narayanan

Srividya Narayanan

Northeastern University, United States
Speaker at Pharma Conferences - Daisy Mills

Daisy Mills

University College London, United Kingdom
Speaker at Pharmaceutical Conference - Maria Richards Brown

Maria Richards Brown

University College London, United Kingdom
Speaker at Pharma Conferences - Gurpreet Singh

Gurpreet Singh

IQVIA, United Kingdom

Submit your abstract Today

Watsapp